Now six products approved using the Pfenex Expression Technology! Merck's 21-valent CAPVAXIVE™ was approved by the US FDA yesterday and uses P. fluorescens-produced CRM197 as its carrier protein! Read more: https://lnkd.in/gH8tFA4p #crm197 #vaccines #pfenexexpressiontechnology
Great news !!
In a less-than-shocking development, the top drugs of the launch class of 2021 were all for preventing or treating everyone’s least favorite virus. Read Josh Slatko's analysis of what drugs led the pack in their first year after launch. https://lnkd.in/e8kdx_nf #pharma #biopharma #vaccines #druglaunch #COVID #MedAdNews
Pfizer’s new meningococcal vaccine, Penbraya, approved for broader protection in teens and young adults https://lnkd.in/dBuFD47i #digitalhealth #healthtech #innovation #hospitals #healthscience #technology #Covid19 #Vaccines #pharmaceuticals #manufacturing #healthcare #regulatory #policies #funding #investment
Monkeypox Vaccine And Treatment Market The Monkeypox Vaccine And Treatment Market Size is valued at 79.09 Million in 2022 and is predicted to reach 212.34 Million by the year 2031 at an 11.98 % CAGR during the forecast period for 2023-2031. Get Free Request Sample:https://lnkd.in/gHE6YS7m Read Press Release: https://lnkd.in/dfSBcPuz #Monkeypox #Vaccine #Treatment #marketreaserch #marketreaserchreport
Elderly #rsv vaccines set to rake in remarkable US$10.5 billion annually by 2030 in G7 Nations: Report https://lnkd.in/eXSwcdqw #digitalhealth #healthtech #innovation #hospitals #healthscience #technology #Covid19 #Vaccines #pharmaceuticals #manufacturing #healthcare #regulatory #policies #funding #investment
(Pharmacovigilance / Vaccines / Common Ingredients) If you've been on the sharp end of a vaccine needle, you may want to know what you're getting. Some good explanations on what is the role of aluminum, antibiotics, formaldehyde, stabilizers, preservatives, and bovine serum in vaccines on this FDA info webpage. Enjoy. #fda #vaccines #cber #biologics #drugs #ingredients #adjuncts (BTW, I recently received 3 different vaccines in one sitting (Covid, Flu, Zoster) and the takeaway is... Don't Do It (Time-efficient but not the smartest thing to do).
Safety surrounding vaccines is so commonly discussed, especially in this post-COVID era. I recommend this read to better understand: - Why people choose to vaccinate - How effective vaccines are - How vaccines are monitored and approved for safety We are collaborating with the FDA, Pfizer, Johnson & Johnson, AstraZeneca, Moderna, World Health Organization, Medicago to develop dynamic and fundamental conversations on Vaccine Safety at World Drug Safety Congress Americas 2023. https://lnkd.in/eq9FcWQT #pharmacovigilance #vaccinesafety #drugsafety #worlddrugsafety
COVID-19, Flu, and RSV Vaccine Skepticism Still an Issue Among ... - AJMC.com Managed Markets Network >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #pharmaceutical #competitivemarketing #healthcare
FDA Grants Expanded Approval: Merck's Ervebo Now Approved for Children 12 Months and Older Merck's Ervebo vaccine has received expanded approval from the FDA and the CHMP, allowing its use for preventing Zaire ebolavirus disease in individuals aged 12 months and older in the US and EU. This milestone comes after its initial approval for those aged 18 and above. However, its protection against other Ebolavirus types and Marburgvirus remains uncertain. The vaccine's effectiveness alongside antiviral medications and immune globulin is yet to be established. With over 500,000 doses already delivered to the global stockpile, the world is better prepared to combat future outbreaks. Awaiting final decisions, the anticipation builds for its potential impact. If you are interested in continuing to read more about this news and staying updated with the Latest Pharma News, visit "Pharmtales," a reliable source for the most recent pharma news. #pharma #pharmaceutical #pharmatles #latestnews #pharmanews #pharmaceuticalindustry #fda #fdaapproval #merck https://lnkd.in/dAdE7ZyF
Protection by Moderna’s mRNA vaccine against RSV displays shorter durability than Pfizer’s and GSK’s vaccines. Moderna’s shot shows an efficacy of 50% in preventing RSV after 18 months, whereas the vaccines by Pfizer and GSK protected 78% over a second year. #RSV #health #globalhealth #publichealth #medicine #biotechnology #medicine #pharmaceuticals #FDA #CDC #WHO #vaccines https://lnkd.in/g4_krZYp
Vaccine Innovators – the unsung heroes! While headlines often highlight groundbreaking advancements in vaccine development during global health crises, it's important to recognize the steady and ongoing efforts of companies that create everyday vaccines. Find out more at https://lnkd.in/ePsVYkTM #Pharmacy #Vaccine #Pharmaceuticals
Crushing it